European Pharma Giants Sound Alarm: 'We Are Losing Ground' to US and China

In a striking plea, leaders of nine major European pharmaceutical companies, including AstraZeneca, GSK, and Novo Nordisk, have warned that the continent is "losing ground" to American and Chinese rivals in the race for innovation and investment. They have called on national leaders, including Andy Burnham, to take immediate action to ensure the future viability of their businesses.

The letter highlights concerns about the increasing dominance of non-European firms in developing new drugs, raising serious questions about the continent's ability to foster a competitive pharmaceutical environment. As these companies seek to safeguard their interests, citizens must ask: what measures are being taken to protect this vital industry, and who will be held accountable if Europe continues to fall behind?

This urgent message comes at a time when public welfare and access to affordable medications are paramount. The implications of a weakened pharmaceutical sector could have severe consequences for healthcare systems across Europe. According to The Guardian, the situation calls for immediate attention from policymakers to ensure that Europe's pharmaceutical industry can thrive in an increasingly competitive global environment.

Source: The Guardian